Treatment of immune competent mice bearing syngeneic tumors resulted in tumor rejection or growth delay that was both PD-L1 and CD8+ cell dependent, demonstrating crosstalk between adaptive T cell immunity, tumor cell PD-L1 expression and sensitivity to PD-L1 CAR haNKs. This evidence concerns the gene CD8A and neoplasm.